Drug Profile
MKC 1106-MT
Alternative Names: MKC 1207; MKC1106-MT; pSEM; Synchrovax™ SEMLatest Information Update: 11 Feb 2016
Price :
$50
*
At a glance
- Originator CTL ImmunoTherapies Corporation
- Developer Colby Pharmaceuticals; MannKind Corporation
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malignant melanoma